Showing 9451-9460 of 18069 results for "".
- New IL-13/IL-31R Bispecific Antibody Data Presented at EAACIhttps://reachmd.com/news/New-IL-13-IL-31R-Bispecific-Antibody-Data-Presented-EAACI/2475170/A new IL-13/IL-31R bispecific antibody demonstrated ability to simultaneously suppress the inflammatory and pruritogenic pathways in atopic dermatitis (AD), according to preclinical study data presented at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025 in Glasgow, S
- Harnessing Llama Antibodies and VR for Infection Preventionhttps://reachmd.com/news/harnessing-llama-antibodies-and-vr-for-infection-prevention/2475128/Harnessing llama-derived antibodies and immersive virtual reality training marks a new frontier in preventing and containing infections that evade traditional controls. Healthcare-associated infections continue to challenge clinicians,
- Emerging Synergies in Combating Antimicrobial Resistance: Education Meets Innovationhttps://reachmd.com/news/emerging-synergies-in-combating-antimicrobial-resistance-education-meets-innovation/2475129/Antimicrobial resistance is eroding the effectiveness of cornerstone therapies and accelerating the emergence of drug-resistant pathogens, demanding simultaneous amplification of public understanding and rapid incorporation of novel treatment
- Oculomics: A Non-Invasive Window into Systemic Diseaseshttps://reachmd.com/news/oculomics-a-non-invasive-window-into-systemic-diseases/2475136/As clinicians face the challenge of detecting systemic diseases before irreversible damage occurs, oculomics is emerging as a non-invasive window into cardiovascular, neurodegenerative, and oncologic pathology. Recent studies have expl
- Evolving Euthanasia Laws and Their Impact on Clinical Practicehttps://reachmd.com/news/evolving-euthanasia-laws-and-their-impact-on-clinical-practice/2475143/The inherent tension between evolving euthanasia laws and end-of-life care creates significant variability in physician practice and patient options, yet the influence of legal frameworks on assisted dying remains underrecognized in clinical
- Photon Counting Detector CT in Pediatric Imaging: Enhancing Precision and Reducing Radiationhttps://reachmd.com/news/photon-counting-detector-ct-in-pediatric-imaging-enhancing-precision-and-reducing-radiation/2475138/Photon counting detector CT (PCD-CT) has been shown to enhance diagnostic precision and reduce radiation exposure in pediatric imaging. For instance, a study comparing PCD-CT with energy-integrating detector CT (EID-CT) in pediatric temporal
- Enhancing Dental Implants with Natural Sensory Feedbackhttps://reachmd.com/news/enhancing-dental-implants-with-natural-sensory-feedback/2475139/Restoring the biomechanics of natural dentition in implantology is a significant focus for oral surgeons, as emerging dental implant technologies now aim to replicate real-time sensory feedback and adaptive wear patterns. Traditional d
- Early Intensive Therapy and Immunization in Psoriatic Arthritishttps://reachmd.com/news/early-intensive-therapy-and-immunization-in-psoriatic-arthritis/2475137/Early intensive therapy in psoriatic arthritis (PsA) and robust immunization protocols are redefining care pathways, offering the potential to alter disease trajectories and protect patients from complications of immunosuppression. Rhe
- Bimekizumab 3-Year Data Shows Lasting Efficacy, Control of Inflammation for PsA, axSpAhttps://reachmd.com/news/Bimekizumab-3-Year-Data-Shows-Lasting-Efficacy-Control-Inflammation-PsA-axSpA/2475126/Bimekizumab (BIMZELX®) demonstrated sustained control of inflammation and deep efficacy in patients living with psoriatic arthritis (PsA) and active axial spondyloarthritis (axSpA), according to new 3-year data from phase 3 trials and open-label extensions in adults with active PsA and active axS
- New Monoclonal Antibody Approved for Infant RSV Protectionhttps://reachmd.com/news/new-monoclonal-antibody-approved-for-infant-rsv-protection/2475116/Respiratory syncytial virus presents a formidable challenge to infant health, driving seasonal surges in hospitalization and respiratory distress that often outpace currently available preventive measures. For pediatricians and neonato